2seventy bio, Inc. (TSVT)
(Delayed Data from NSDQ)
$4.40 USD
+0.06 (1.38%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.14 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | 17.14% |
ABR | 2.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.69 |
Next Year | 0.05 |
EPS (TTM) | -3.21 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 20.22M | 25.79M | 65.21M | 89.45M |
# of Estimates | 3 | 2 | 3 | 3 |
High Estimate | 25.50M | 27.40M | 74.40M | 101.15M |
Low Estimate | 17.00M | 24.18M | 57.50M | 83.40M |
Year ago Sales | 12.03M | 10.68M | 100.39M | 65.21M |
Year over Year Growth Est. | 68.05% | 141.48% | -35.04% | 37.17% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.14 | -0.02 | -0.69 | 0.05 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.07 | 0.04 | -0.59 | 0.40 |
High Estimate | -0.07 | 0.04 | -0.59 | 0.40 |
Low Estimate | -0.20 | -0.07 | -0.79 | -0.30 |
Year ago EPS | -1.00 | -1.11 | -4.42 | -0.69 |
Year over Year Growth Est. | 86.00% | 98.20% | 84.39% | 107.25% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.14 | -0.02 | -0.69 | 0.05 |
7 Days Ago | -0.14 | -0.02 | -0.69 | 0.05 |
30 Days Ago | -0.14 | -0.02 | -0.69 | 0.05 |
60 Days Ago | 0.08 | 0.10 | -0.44 | 0.55 |
90 Days Ago | 0.01 | 0.02 | -1.06 | 0.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | -0.02 | -0.69 | 0.05 |
Zacks Consensus Estimate | -0.14 | -0.02 | -0.69 | 0.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.81 | -1.11 | -1.00 | NA |
Estimate | -0.35 | -0.72 | -1.22 | -1.31 | NA |
Difference | 0.06 | -0.09 | 0.11 | 0.31 | 0.10 |
Surprise | 17.14% | -12.50% | 9.02% | 23.66% | 9.33% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more